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Abstract
The potential environmental impact of nanomaterials is a critical concern and the ability to assess these potential impacts is top
priority for the progress of sustainable nanotechnology. Risk assessment tools are needed to enable decision makers to rapidly
assess the potential risks that may be imposed by engineered nanomaterials (ENMs), particularly when confronted by the reality of
limited hazard or exposure data. In this review, we examine a range of available risk assessment frameworks considering the
contexts in which different stakeholders may need to assess the potential environmental impacts of ENMs. Assessment frameworks
and tools that are suitable for the different decision analysis scenarios are then identified. In addition, we identify the gaps that cur-
rently exist between the needs of decision makers, for a range of decision scenarios, and the abilities of present frameworks and
tools to meet those needs.
Introduction
Engineered nanomaterials (ENMs) are increasingly being used
in numerous industrial products and processes owing to their
unique physicochemical properties. There are over 1000 nano-
enabled consumer products [1], representing an estimated
global and US markets of $1 trillion and $800 billion, respec-
tively [2]. Applications of ENMS include, for example, nano-
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medicine (e.g., drug delivery, early diagnosis and therapy for
chronic diseases) [3] and environmental remediation [4].
Given the rapid growth of the market for ENMs, there is
concern about potential adverse impacts from possible expo-
sures to ENMs during production, distribution, use, and
disposal [5]. Human exposure to ENMs can occur through
inhalation, ingestion or dermal absorption. Despite the fact that
chronic health effects of ENMs have not been conclusively
identified in human populations [6], animal studies suggest that
the ENMs exhibit mechanisms of respiratory toxicity similar to
those of ambient ultrafine particles (UFPs) [7]. Furthermore, in
vitro and in silico studies [8,9] suggest that inhalation of some
ENMs may cause additional adverse outcomes, such as damage
to the respiratory tract, inflammation, and activation of
signaling pathways. For additional routes of exposure, such as
dermal absorption, existing evidence suggests that certain
ENMs may penetrate the skin (e.g., cobalt nanoparticles in
human volunteers and quantum dots ‘QDs’ in rat skin) and
cause irritation (e.g., nano ZnO in zebrafish models) [10]. Oral
exposure to ENMs can result in subsequent absorption in the GI
tract and organ damage (e.g., nano Cu in mice via oral gavage
damaged liver, spleen and kidneys, and nano ZnO caused
necrosis of liver tissues and severe renal damage) [10]. Given
the above concerns, decision-makers and relevant stakeholders
are confronted with the need to identify and utilize reliable
methods to ascertain environmental impacts related to the pro-
duction, use and disposal of ENMs.
The default process for evaluating the potential impacts of
ENMs would be to use existing frameworks that were de-
veloped to assess the environmental health and safety (EHS)
impacts of new chemicals and new industrial technologies more
broadly. One such general framework is Environmental Impact
Assessment (EIA), which was promoted within the National
Environmental Policy Act (NEPA) in the early 1970’s [11] as a
holistic approach that considers the environmental, social and
economic implications of planned projects. Another existing
general framework is “risk assessment” (RA) [12], which was
developed to estimate human health related risks in a system-
atic manner based on toxicity, dose response curves and quanti-
tative exposure assessment. These frameworks (i.e., EIA and
RA) have also been incorporated into ecological risk assess-
ment (ERA) [13], which is used to evaluate the likelihood of
adverse environmental effects with focus on ecological recep-
tors (e.g., biota, environmental compartments) [14]. However,
application of these existing frameworks to ENMs is not
straightforward. For example, although RA methods for chemi-
cals are well established, their adoption and/or adaptation
for ENMs would require consideration of various issues
that include, but are not limited to the: behavior of ENMs in
various media (e.g., dissolution, agglomeration/aggregation,
adsorption); persistence (techniques to predict aspects of degra-
dation of certain ENMs; transportation/distribution; predicted
environmental concentrations (PECs) and transformation prod-
ucts and impurities; bioaccumulation; and effects/predicted no
effect concentration (PNEC) [15,16] (see Figure 1). As a result,
the implementation of RA for ENMs would be extremely costly
and time consuming. Additionally, challenges such as the
lack of information on background levels of naturally occurring
nanoparticles and needed monitoring data on environmental
concentrations of ENMs [17] restrict the application of
traditional RA and EIA to ENMs. Furthermore, the adaptation
of chemical RA to ENMs would require the development
of data on: (i) ENMs hazard properties, (ii) ENMs dose-
response and dosimetry metrics, (ii) production volume and
emission rates (including modes of release) of ENMs,
(iii) environmental transformations, and (iv) distribution of
ENMs in the environment and associated multimedia exposure
levels [15,16].
Due to data gaps, RA of ENMs that have been performed to
date have frequently had to rely on expert judgment, which can
result in ongoing debates about the validity of the results ob-
tained from this approach [16,18]. Furthermore, the complexi-
ties of ENMs transformations (e.g., agglomeration, complex
formation) make it difficult to quantify the relevant ENM
absorbed and/or effective doses and complicate the develop-
ment of dose–response relationships.
As defined by the United States Environmental Protection
Agency (US EPA), “Risk characterization is an integral compo-
nent of the risk assessment process for both ecological and
health risks, i.e., it is the final, integrative step of risk assess-
ment…risk characterization integrates information from the
preceding components of the risk assessment and synthesizes an
overall conclusion about risk that is complete, informative, and
useful for decision makers” [19]. Evidence regarding the
harmful impacts of chemicals has been traditionally addressed
via toxicity and epidemiological studies, which allow risk asses-
sors to establish causal relationships between exposure and
effects. Risk characterization for chemicals entails quantitative
integration of exposure assessment and dose–response informa-
tion, and the metrics include the establishment of reference
doses (e.g., to protect the susceptible population from harmful
effects), hazard index and cancer potency factors. By contrast,
the bulk of available toxicity data for ENMs are mostly based
on in vitro assays and modeling approaches (e.g., quantitative
structure activity relationships (QSARs)). For exposure assess-
ment, the RA process for chemicals has been traditionally per-
formed via laboratory studies, field monitoring, use of biomark-
ers, or fate and transport modeling. The RA process for ENMs,
Beilstein J. Nanotechnol. 2017, 8, 989–1014.
991
Figure 1: Challenges encountered at each step of the traditional risk assessment process for conventional chemicals and its relevance to ENMs.
on the other hand, involves the additional complexity associat-
ed with having to address the impact of particle size distribu-
tion and agglomeration on the fate and transport and bio-uptake
of ENMs by ecological receptors.
Given the complexity of quantifying environmental exposures
to ENMs and the scarcity of toxicity data at the organism level,
several alternative approaches have been proposed (as an alter-
native to RA or EIA) for assessing the potential environmental
impacts of ENMs. Previous reviews of the above approaches
[1,20,21] have provided insight into the various elements of the
assessment methods, but did not assess whether they meet the
needs for ENMs RA and the associated challenges faced by the
multiplicity of stakeholders for specific decision-making
scenarios. Here, we provide a critical assessment of
1. the types of decisions that different stakeholders in regu-
latory and non-regulatory environments need to make
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about the risk potential of ENMs and what types of tools
they require;
2. which of the existing frameworks may be most suitable
to address these needs; and
3. the gaps that exist between the needs of decision makers
and the RA tools that are currently available.
Methods
Delineation of decision-making scenarios
To assess the relevance of the different risk assessment ap-
proaches, six different plausible decision-making scenarios
were considered. The term “scenario” has been used across dif-
ferent fields and practices with different meanings and uses
[22], ranging from management and planning (e.g., a descrip-
tion of future events to identify key variables and questions,
trends and actors to identify strategic options) [23] to software
design (e.g., envision of potential problems related to the use of
the developed product) [24] and environmental assessment
(e.g., assessment of pathways of events under a set of key
assumptions (‘what if’?)) [25]. A common ground for the differ-
ent uses of scenario analysis is in its application as a tool to
study multi-disciplinary problems. Within the context of frame-
work analysis in this review, “scenarios” are defined as a set of
equally plausible contexts in a narrative form [22]. In the
present review the example scenarios were selected with a focus
on the United States landscape considering various frameworks
reported in the published literature. The first four scenarios are
related to manufacturing ENMs and occupational health and
safety concerns, and the last two scenarios are related to regis-
tration of new ENMs and establishment of maximum allowable
exposure levels. Evaluation of RA frameworks within the
context of decision-making scenarios is particularly instructive
in assessing the utility of specific RA methods [26]. The specif-
ic information needs for each decision-making scenario include:
1. definition of the intent of the analysis (e.g., selection of
hazard identification, exposure assessment or risk char-
acterization);
2. the level of resolution/type of the analysis result (e.g.,
qualitative categorization/prioritization of needed
research or testing or quantitative information, for exam-
ple, a permissible exposure limit (PEL));
3. the typical level of expertise of stakeholders who would
be making the decision;
4. the type of data accessible to stakeholders (e.g., data re-
ported from the literature, publicly available production
reports, material safety data sheets (MSDS), etc.).
Scenario I reflects a process by which a company must decide
whether to control exposure to workers during manufacturing or
processing of ENMs. This is a common assessment carried out
in industry to ensure occupational health and safety standards,
require information about process details and potential expo-
sures, and establish control practices.
Scenario II is for the establishment of safe exposure levels
related to occupational health by a regulatory body (e.g., the US
Occupational Safety and Health Administration (OSHA)).
OSHA requires information to drive risk management (e.g.,
establishment and enforcement of occupational exposure limits
(OELs) and permissible exposure limits (PELs) and guidance
for compliance). The main needs of this scenario are to estab-
lish OELs/PELs for a specific class of ENMs for which the
agency is required to provide evidence based exposure limits.
Scenario III is for a company manufacturing ENMs that has to
decide whether risk associated with such ENMs or products
containing ENMs is manageable and how to manage any poten-
tial risks. This decision-making scenario requires information/
data regarding the potential for exposure throughout the ENM’s
life cycle and the hazards it may pose to humans and the envi-
ronment.
Scenario IV addresses the need for arriving at a decision by a
company or regulatory agency for choosing the safest ENM out
of a group of alternatives (ENMs or chemicals). In this scenario,
the assessment of alternatives requires information regarding
hazard posed to humans and the environment for all different al-
ternatives as well as technical performance of the material for
the intended application.
Scenario V focuses on decisions made by a regulatory body
(i.e., the US EPA) about whether to control the use, release, or
emissions of an ENM via a Significant New Use Rule (SNUR).
This decision entails gathering substantial evidence that indi-
cates any unreasonable risk to people or the environment given
information about production volume, release, exposure poten-
tial and anticipated hazards. The SNUR must be justified
considering:
1. the projected ENM volume of manufacturing and pro-
cessing;
2. the extent to which ENM use changes the type or form of
human and ecological receptors’ exposure to the ENM;
3. the extent to which the ENM use increases the exposure
level and period;
4. the reasonably anticipated manner and methods of manu-
facturing, processing, distribution in commerce and
disposal of a chemical substance [27].
Scenario VI focuses on decisions involving food, drugs or
personal care products. In this scenario, a regulatory body (i.e.,
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the US Food and Drug Administration (FDA)) needs to decide
whether to allow registration of a new nano-enabled product in
food, drugs and personal care products. In Scenario VI, exam-
ples are explored that pertain to cosmetics and new drugs con-
taining ENMs [28]. While safety assessment is required for both
product types, new drugs require a detailed Risk Evaluation and
Mitigation Strategy (REMS) [29], including an estimation of
population exposed to the drug, benefits from treatment with the
drug, potential health risks, and if the drug represents a new
molecular entity [30].
Review of available frameworks in the
context of specific decision-making scenarios
18 existing frameworks that are potentially useful for assessing
the impacts of ENMs were evaluated. These frameworks can be
categorized as follows: (1) hazard identification frameworks,
(2) frameworks for environmental risk/impact characterization,
and (3) frameworks for occupational risk characterization. The
evaluated hazard identification frameworks were the Swiss
Precautionary Matrix (SPM) [31], Risk Classification System
based on Multi Criteria Decision Analysis (MCDA risk classifi-
cation) [32-34], NanoRiskCat [35], the Decision-making frame-
work for the grouping and testing of nanomaterials (DF4Nano
grouping) [36], and the modified GreenScreen [37]. The evalu-
ated frameworks for environmental risk/impact characterization
were Life Cycle Analysis (LCA) [38-40], DuPont’s NanoRisk
[41], US EPA’s Comprehensive Environmental Assessment
(CEA) [42,43], NanoHAZ [44], Nanomaterial risk screening
tool (NRST) [45], Engineered Nanoparticles – Review of
Health and Environmental Safety: Human health and Ecologi-
cal Risk Assessment (ENRHES RA) [46], Risk Quantification
based on Probabilistic Mass Flow Modeling Analysis (PMFA
Risk Assessment) [47], Forecasting of the Impacts of Nanoma-
terials in the Environment (FINE) based on Bayesian Networks
(BN) [48], and Life Cycle Risk Analysis for nanomaterials
(Nano LCRA) [49,50]. The assessed frameworks for occupa-
tional risk characterization were Risk based classification for
occupational exposure control (Risk based OEL) [51], Risk
Classification based on an Industry Insurance Protocol (RCIP)
[52], CB Nanotool [53] and the Web-Based Tool for Risk Prior-
itization of Airborne Manufactured Nano Objects (Stoffenman-
ager Nano) [54].
The potential for using existing frameworks for environmental
impact/risk assessment and other relevant health and safety
assessment of ENMs was evaluated systematically (see Sup-
porting Information File 1) by identifying the following charac-
teristics for each framework:
1. The intent of the analysis based on the framework’s main
elements of the risk assessment process (e.g., hazard
identification, exposure assessment, and risk characteri-
zation);
2. The inputs required to conduct the analysis (e.g., envi-
ronmental fate and transport data, physicochemical prop-
erties; toxicological information including dose–response
information);
3. The outputs/results obtained from the analysis such as
description of the outcome (e.g., predicted values of
environmental concentration, probability of risk) and its
category (e.g., quantitative value/magnitude, qualitative
classification) relative to the analysis intent;
4. The intrinsic characteristics of the applied methodolo-
gies including, for example, the basis for the analysis
(e.g., conceptual model, questionnaire, statistical
model), settings or conditions for which the framework
was designed (e.g., a specific geographical location, a
particular working environment) and data used to
suppor t  the  des ign  of  the  f ramework  (e .g . ,
experimental data, mechanistic studies, authors’ assump-
tions);
5. The capability of a framework to address data gaps (e.g.,
via consideration of expert judgment or modeling tools
incorporated in the framework); and
6. The availability of software tools specifically designed to
conduct the analysis.
Finally, a discussion is provided of the potential opportunities
for improving and/or adapting current frameworks and to
further develop recommendations for the development of future
tools. Moreover, the reviewed frameworks and the correspond-
ing required information were further evaluated within the
context of the selected decision-making scenarios in order to
identify remaining major challenges.
Review
The basic characteristics of the 18 frameworks that were evalu-
ated are summarized in Table 1. Below, we summarize the
intent, inputs, outputs, intrinsic characteristics, ability to address
data gaps, and availability of software tools for each of the
frameworks. The frameworks were evaluated, as detailed in the
following sections, according to their intended applications for
hazard identification, characterization of environmental risk,
and characterization of occupational risk.
Hazard identification frameworks
The following four frameworks for identifying hazards associat-
ed with engineered nanomaterials were assessed: (a) the Swiss
Precautionary Matrix, (b) “Risk” Classification Systems Based
on Multi Criteria Decision Analysis, (c) NanoRiskCat, and
(d) Decision-making framework for the grouping and testing of
nanomaterials. Although several of the above approaches
Beilstein J. Nanotechnol. 2017, 8, 989–1014.
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Table 1: Summary of critical characteristics of existing risk assessment frameworks relevant to ENMs.
Name of the framework and
developer
General description Main output of analysis
Swiss precautionary matrix [31]
(Swiss Federal Office of Public
Health)
Decision tree/questionnaire about the ENM
properties under consideration (e.g.,
dimensions), effects (e.g., reactivity, stability),
and exposure/release potential (e.g., physical
form of the ENM), suitable for pre-screening.
Classification of the hazard posed by the
ENM into two main groups: A) no need for
review of (unspecified) risk management
measures; B) need for review of
(unspecified) risk management measures
or need for additional information.
Risk Classification System based
on Multi Criteria Decision Analysis
(MCDA risk classification) (various
institutions) [32-34].
Systematic comparison of alternatives (ENMs)
via outranking by assigning scores (e.g.,
qualitative scale of least-most desirable (1–4),
subjective probability (0–100%), and quantitative
measurement of size (0–100)) for
pre-determined criteria related to hazard,
including intrinsic ENM properties (e.g.,
agglomeration, reactivity/charge, critical function
groups, contaminant dissociation and size) and
factors affecting toxicity (bioavailability and
bioaccumulation).
Categorical classification of the hazard
(e.g., toxic potential): very low, low,
medium, high, and extremely high.
Hazard and exposure potential
identification for ENMs in
consumer products (NanoRiskCat)
[35] (University of Denmark).
Decision tree/flowchart, where user answers
“yes”, “no”, or “no data” to questions about the
ENM of interest (e.g., physical form of the ENM
applied to products, toxicity evidence, high
aspect ratio, potential of transport across
ecosystems).
Color-coded/categorical classification of
the hazard posed by the ENM: the scale
ranges from a grey color assigned to
insufficient data, green-low hazard,
yellow-medium and red-high.
DF4Nano grouping [36]
(European Center for
Ecotoxicology and Toxicology of
Chemicals “ECETOC” (NGO)).
Theoretical framework presented in tables (e.g.,
threshold values obtained from published data
and expert elicitation) to guide the user in the
classification/prioritization of ENMs for additional
testing/risk assessment.
Categorical classification of ENMs in four
main categories: 1) soluble ENMs, 2)
biopersistent high-aspect ratio (for which
no additional testing is required), 3)
passive ENMs, and 4) active ENMs
(which require a further analysis/risk
assessment).
Modified GreenScreen [37] (Clean
Production Action Group (NGO)).
Hazard assessment framework designed to
screen chemicals based on a range of toxicity
endpoints and ENM physicochemical properties.
Categorical classification of ENMs in 5
main categories of aggregated
benchmark (BM) scores to designate
specific recommendations regarding ENM
use based on the potential environmental
and human health concerns as supported
by available data.
Life Cycle Analysis (LCA) [38-40]
(Various institutions).
Class of approaches that follow a product over
its life stages, including: (a) material acquisition
and purification, (b) manufacturing and
fabrication, (b) commercial uses, and
(d) end-of-life product management.
Environmental impacts of the product
under analysis (e.g., effects on ecological
receptors, potential CO2 emissions
attributed to synthesis/manufacture of
ENMs).
include “risk” in their titles, in practice they have been used
either to solely assess hazard and/or do not yield a combined
risk score. As a result, the above frameworks that are summa-
rized below are considered in the present review as a category
separate from those frameworks that have been used to identify
risks associated with ENMs.
The Swiss Precautionary Matrix (SPM) was designed as a
response to the Swiss Action Plan on Synthetic Nanomaterials
(SAPSN) to employ existing information to identify potential
harmful impacts of synthetic nanoparticles on health and the
environment [31]. The SPM, which is available as a web-tool
[56], is not designed to be a comprehensive risk assessment
framework, but rather to provide an initial screening approach
to determine the required measures for safe handling of nano-
materials in Switzerland [31]. Prior to evaluating a specific
ENM or a nano-enabled product using the SPM, the analyst has
to assess whether that material or product meets the definition
of “nano-relevant” using the European Union regulatory recom-
mendation of 2011 [57]. According to this recommendation, a
nanomaterial is defined as “an unknown material containing pri-
mary particles in an unbound state or as an aggregate or as an
agglomerate and where, for 50% or more of the primary parti-
cles in the number size distribution, one or more external
dimensions is in the size range 1–100 nm or if the number size
distribution is unknown”. A material is also considered to be
“nano-relevant” by this definition if its specific surface area per
unit volume is greater than 60 m2/cm3, or it is a material that
Beilstein J. Nanotechnol. 2017, 8, 989–1014.
995
Table 1: Summary of critical characteristics of existing risk assessment frameworks relevant to ENMs. (continued)
DUPONT’s Nanorisk [41]
(Environmental Defense Fund
(NGO) and DuPont (Industry)).
Systematic collection and organization of
information, that can include a chemical process
risk assessment (CPQRA) following AICHE
guidelines in cases where sufficient quantitative
data are available. CPQRA focuses on acute
rather than chronic hazards. Risk in this system
is defined as a function of a hypothetical
scenario, the estimated consequence(s) of
exposure, and the estimated exposure
frequency.
Results for individual ENMs and
scenarios are presented as lifecycle
profiles that include information on
physicochemical properties, ecotoxicity,
and environmental fate to be used for risk
management strategies. In cases where
quantitative data are available, the results
include a quantitative risk analysis of the
industrial processes related to the ENM.
US EPA’s Comprehensive
Environmental Assessment CEA
[42,43] (US EPA).
Compilation of extensive information needed to
inform a “collective judgment”. Experts must then
analyze the information to provide guidance to
decision makers such as research planners and
risk managers. This framework is presented as a
roadmap to guide the user in a systematic
data collection and identification of critical data
gaps.
Summary of available information
regarding a specific ENM. Typically
accompanied by an evaluation of the
resulting information by a group of
experts that provides recommendations
for research priorities and risk
management.
An Adaptive Screening-Level Life
Cycle Risk-Assessment
Framework for Nanotechnology
(Nano LCRA) [50,55] (Vireo
Advisors).
Systematic compilation of information (e.g.,
properties, potential exposure and hazard of
ENMs through all life cycle stages for a particular
product) guided by a “roadmap” that is further
analyzed by experts.
Summary of information with main
findings/expert judgment based on those
findings and indication of further
information needs.
Ranking initial environmental and
human health risk: Nano HAZ
framework [44]
(University College Dublin).
Process for developing qualitative risk rankings,
including ecological risk and/or human health
risk, for ENMs. Risk rankings reflect Bench Mark
Dose (BMD) calculations, which are based on
published/available data.
Categorical classification of ENMs into
relative risk ranking groups: 0–2 (low
environmental or health risk on a relative
basis), 3–4 (concentrations that require
monitoring and potential action), 5 +
(environmental concentration above those
provisional regulatory and toxicological
limits as set in this study).
Nanomaterial risk screening [45]
(University of British Columbia and
Decision Research (non-profit
organization)).
The framework guides the user through the
process of assigning risk groups to ENMs. The
categories are determined based on
comparisons between data for the ENM under
analysis to a reference set of information (tables)
provided by the framework.
Categorical classification of ENMs in risk
groups, where lowest concern = 1 and
highest concern = 5.
Engineered Nanoparticles –
Review of Health and
Environmental Safety: Human
health and Ecological Risk
Assessment (ENRHES RA) [46]
(European Commission Institute
for Health and Consumer
Protection).
Risk assessment of specific ENMs based on
90-day exposure studies and likely
environmental concentrations determined by
probabilistic models.
Ratio of the predicted environmental
concentration for ENM of interested to the
(predicted) concentration at which there is
no effect (related to human health;
PEC/INEC).
A risk quantification based on
probabilistic mass flow analysis
(PMFA risk quantification) [47]
(Swiss Federal Laboratories for
Materials Science and Technology
(EMPA)).
Risk assessment for ENM of interest that
combines predicted environmental
concentrations (determined via probabilistic
modeling) with a species sensitivity distribution
(e.g., probability distribution of harmful effects
shown at different concentrations for a given
ENM).
Quantitative measure of risk calculated
from the product of the probability of
critical environmental concentrations and
the probability that organisms would
potentially be negatively impacted by
such concentrations.
Bayesian Networks based FINE
(Forecasting the Impacts of
Nanomaterials in the Environment
applied to nanoAg) [48] (Center for
the Environmental Implications of
NanoTechnology (CEINT) at Duke
University).
Method for calculating the probability of risk for
an ENM of interest using a Bayesian Network
designed with inputs from expert judgment.
Modified version of a deterministic risk
quotient (quantitative measure of risk) in a
probabilistic expression.
Risk based classification for
occupational exposure control
(Risk based OEL) [51]
(Nanotechnology Research Center
(NTRC) and National Institute for
Occupational Safety and Health
(NIOSH)).
Process for quantitatively assessing the risk
associated with the ENM of interest by applying
benchmark doses (BMD).
Percent excess risk related to a specific
health outcome as a result of exposure to
the ENM under analysis.
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Table 1: Summary of critical characteristics of existing risk assessment frameworks relevant to ENMs. (continued)
Risk classification based on an
Industry Insurance Protocol (RCIP)
[52] (Rice University, Golder
Associates Inc and XL insurance).
Comparison of scores assigned to
characteristics of the target industrial process
with pre-established scores from an insurance
protocol.
Relative risk ranking for the ENM process
compared to conventional industrial
chemical process.
Control Banding: CB Nanotool [53]
(Delft University of Technology).
Classification based on characteristics of the
potential for exposure during preparation the
ENM of interest (e.g., estimated amount of
ENMs, dustiness/mistiness, number of
employees with similar exposure, frequency and
duration of operation) and properties related to
hazard of the ENM (e.g., surface chemistry,
particle shape and diameter, solubility,
carcinogenicity, reproductive toxicity,
mutagenicity, dermal hazard potential).
Risk banding of occupational risks. The
risk bands are intended for developing
recommendations risk management
strategies for exposure control (e.g., RL
1: general ventilation; RL 2: fume hoods
or local exhaust ventilation; RL 3:
containment; RL 4: seek advice of
environmental health specialist).
Web-Based Tool for Risk
Prioritization of Airborne
Manufactured Nano Objects
(Stoffenmanager Nano) [54].
Classification based on the characteristics of the
potential for exposure during preparation of the
ENM of interest (ENM size, aspect ratio,
handling, background exposure, duration,
frequency) and properties related to hazard (e.g.,
toxicity) associated with the ENM.
Priority banding where the bands indicate
the priorities for risk management.
consists of fullerenes, graphene flakes or single wall carbon
nanotubes.
For materials considered to be nano-relevant, the SPM tool can
be used to develop scores representing levels of concern for the
following parameters: potential effect (W), potential exposure
of humans or environmental release (E), and available informa-
tion on the material’s life cycle (I). Threshold values and limits
for each of these parameters (W, E, I), as determined from the
peer-reviewed literature are specified in the SPM guidance
document, which is provided online by the tool developers [31].
The potential effect (W) is a score assigned on the basis of the
ENMs’ reactivity (e.g., redox activity, catalytic activity, oxygen
radical formation potential or induction potential for inflamma-
tion reactions) and stability (e.g., half-life of the nanomaterial in
the human body, or under environmental conditions). For exam-
ple, a metal oxide nanoparticle with a conduction band energy
that is much lower relative to the redox potential of biological
molecules would be given the lowest score (1) on a scale of 1–9
(where 1 is low, 5 is medium and 9 is high). Likewise, a score is
assigned for the ENM period of stability (e.g., 1, 5 and 9 for
hours, days-weeks, and months respectively). The potential for
human exposure to a given ENM and its environmental release
(E) is assessed based on: (a) the carrier material of the ENM
and availability of the ENM for release, (b) the maximum
possible extent of human exposure via inhalation based on the
daily amount of nanomaterial with which a worker comes into
contact; (c) the maximum ENM input into the environment
during manufacture via wastewater, exhaust gases or solid
waste; and (d) the available information on the ENM life cycle.
Finally, the score for (d) the available information on life cycle
(I) is assigned based on the answers the user provides to the
following questions: (i) Is the ENM’s origin (i.e., starting mate-
rial(s)) is known? (ii) Is sufficient information available to com-
plete the SPM based on the ENM starting materials? (iii) Are
users of the ENM known? and (iv) Is the composition/purity of
the ENM known or can be estimated?
Once the categories for each of the assessed parameters has
been determined, an overall score for the nano-relevant materi-
al is calculated, which is expressed as a Precautionary need = f
(N, W, E, I) [31]. The resulting score represents a measure of
the need to review existing measures or evaluate new measures
of risk management related to the nanomaterial. It should be
noted that the SPM framework allows for updating data/infor-
mation given that calculated scores can be high when there is
lack of knowledge. Overall, SPM is a useful approach for
setting priorities for action related to nano-relevant materials.
However, the SPM tool does not identify specific control
measures for risk reduction nor quantifies the risk/impact posed
by the nano-relevant materials in question.
“Risk” Classification Systems Based on Multi Criteria Deci-
sion Analysis (MCDA) has been used as an analytical frame-
work for environmental hazard assessment and/or management
for ENMs, which can also aid in decision support or decision
analysis [58]. Although this approach has been termed “Risk
Classification by MCDA”, to date, use of this approach has
primarily focused on hazard identification; hence for the
purpose of this review it is categorized as a “hazard identifica-
tion” approach [32,58]. The MCDA process involves [32] iden-
tification of stakeholders and evaluation criteria, elicitation of
MCDA parameters (e.g., establishment of weights and thresh-
olds), model execution using available software tools [59], and
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interpretation of results. It is noted that MCDA is often limited
with regard to addressing data gaps, since scores must be provi-
ded by the assessor or via expert elicitation. Integration of
MCDA with Life Cycle Analysis (LCA) and RA has been pro-
posed to compare the impact of ENMs across life cycle stages
[60]. However, case studies based on this integrative approach
have not yet been reported (as of September 2016).
An interesting MCDA example of classifying the risk potential
of ENMs is the “stochastic multi-criteria acceptability analysis”
(SMAA-TRI) approach [34]. In the above approach, ENMs are
classified into “risk” categories (e.g., very low, low, medium,
high and extremely high risk) to provide recommendations for
additional testing prior to ENM use in consumer products [34].
In the SMAA-TRI method, the highest scoring category (i.e.,
extremely high risk) is assigned to ENMs that have high scores
for the majority of the criteria described below. The SMAA-
TRI was utilized [61] to compare a set of ENMs (called “alter-
natives” in the framework) based on selected hazard and toxici-
ty criteria (e.g., extrinsic ENM properties such as agglomera-
tion, reactivity/charge, critical functional groups, contaminant
dissociation and size; evidence of toxicity; and other factors
related to toxicity such as bioavailability and bioaccumulation).
This outranking method has the advantage, when criteria
metrics are not easily aggregated, of providing qualitative
metrics for ENM ranking (e.g., “most-least” favorable) [32].
The SMAA-TRI approach has been demonstrated for ranking of
C60, multi-walled carbon nanotubes (MWCNTs), CdSe, Ag
nanoparticles (NP), and Al NP according to the following
scales: size (quantitative scale 1–100 based on literature review
for the studied ENMs); agglomeration, reactivity/charge, criti-
cal functional groups and contaminant dissociation (qualitative
scale of 1–5, where scores are assigned based on expert judge-
ment with 1 representing the most favorable score as judged
based on the perceived hazard/toxicity (i.e., lower score for less
harmful/toxic ENM) and 5 the least favorable/more toxic); and
toxicity evidence, bioavailability, and bioaccumulation (scale of
0–100 of a “subjective” probability scale constructed by the
authors based on their expert judgment). In the proposed ap-
proach, the authors followed the scoring with a Monte-Carlo
simulation to sample from a given probability distribution for
each parameter to arrive at probabilities for the ranked ENMs
for each of the categories. Such analysis suggested that CdSe
was of greatest concern among the analyzed ENMs, ranking in
the high-risk category with a 98% probability. In contrast, the
ranking for C60 was fairly evenly divided between medium risk
(51% probability) and high risk (49% probability), and Al NP
was fairly evenly divided between medium risk (34% probabili-
ty) and low risk (33% probability) [34]. As illustrated by the
above case study, the Risk Classification MCDA framework is
useful in a context where the ENMs hazards are known and can
be reasonably or rationally grouped within categories for the
intended ranking. However, the assignment of ENMs’ proper-
ties or hazard traits involves subjective expert analysis and
therefore may be biased depending on the knowledgebase avail-
able to the assessor.
NanoRiskCat is a roadmap/flowchart designed as a first-tier
approach to assess and communicate the hazard and exposure
potential of ENMs that are used in consumer products [35]. In
the above approach hazard and exposure potentials are assessed
individually and are not combined to yield a risk score. Thus, in
the current review, NanoRiskCat is categorized as a “hazard
identification framework”. This framework typically requires
expert judgement in order to interpret the available data. In ad-
dition, use of this framework by individuals other than the
developers is currently limited given the present unavailability
of a software implementation of the framework. Nonetheless,
this framework could serve to aid companies and regulators for
assessing the potential exposure, human health and environ-
mental hazards associated with specific ENMs.
The NanoRiskCat framework leads the assessor through a series
of questions that guide through the process of qualitatively clas-
sifying the hazard and exposures potential of the ENM of
concern. Qualitative Classification is expressed in terms of a
color code where red, yellow, green and gray indicate high, me-
dium, and low potential hazard/exposure, respectively, while
gray signifies that data are insufficient for an assessment. Ques-
tions are then posed to allow one to classify the hazard and
exposure potentials; such questions also include queries
regarding the physical form of the ENM and potential receptors
(e.g., professional-end users, consumers and/or environment)
that could be exposed to the ENM. The framework includes
questions about the potential hazards of the ENM with respect
to human health (e.g., evidence of acute toxicity, germ cell
mutagenicity, carcinogenicity, reproductive toxicity) and envi-
ronmental hazards (e.g., adverse outcomes to aquatic and terres-
trial species). Based on answers to the posed questions,
NanoRiskCat classifies ENMs into three categories of potential
exposure (high, medium and low) [62,63]. The potential for
ENM human hazard is also evaluated based on answers to ques-
tions about the ENM aspect ratio (e.g., a high aspect ratio ENM
is categorized immediately as high), evidence of adverse
outcomes related to acute and chronic effect posed by the ENM
(e.g., evidence to support genotoxicity, neurotoxicity, carcino-
genicity, and/or cardiovascular, respiratory toxicity). Environ-
mental impacts are also assessed based on bioaccumulation,
persistence, as well as dispersibility and other “warning signs”
of potential hazard [64]. Given the above, it can be stated that
qualitative results obtained via NanoRiskCat are intended to be
a tool for risk communication strategies.
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The use of NanoRiskCat was demonstrated for categorization of
the following ENM containing products: cleansing soap (con-
taining nano Ag), tennis rackets (CNTs), automotive oil (Fuller-
ene C60), and sunblock (nano ZnO), among others [35].
NanoRiskCat analysis concluded that sunblock and cleansing
soap were in the category of overall red/high exposure potential
for human and for environmental hazards [35]. The tennis
racket, as a source of ENMs, on the other hand, was catego-
rized as being of low potential exposure. However, since the
tennis racket contained CNTs it was designated in the medium/
high category for human and environmental hazard. As demon-
strated in the case study [35], the NanoRiskCat framework can
be a useful tool to qualitatively identify areas of concern (e.g.,
ecological and/or human health hazards) through the analysis of
published information. However, the approach is not built for
direct analysis of quantitative data or handling of areas of
missing information.
The Decision-making framework for the grouping and
testing of nanomaterials (DF4Nano grouping) was designed
by the European Center for Ecotoxicology and Toxicology of
Chemicals (ECETOC) “Nano Task Force” as a regulatory
framework to guide the users on grouping ENMs to make
human health hazard assessment and identify information
needs/research priorities for inhaled ENMs [36]. This frame-
work leverages the concept of “read-across”, which allows data
gaps to be filled assuming that ENMs with similar structures
and/or physicochemical properties will exhibit similar hazard
profiles [36]. The Nano Task Force proposed that this frame-
work could be useful for categorizing substances into common
groups based on similarity of structural and physicochemical
properties that induce similar patterns of toxicity.
In DF4Nano, ENMs are grouped into four main categories:
soluble ENMs, biopersistent high aspect ratio (HAR) ENMs,
passive ENMs, and active ENMs. Soluble ENMs are defined as
ENMs with a water solubility that exceeds 100 mg/L or not
water-soluble but soluble in biological media and/or if the ENM
has a pulmonary half-life of less than 40 days. For soluble
ENMs, no further nano-specific sub-grouping is specified and
read-across of the properties of the dissolved materials to the
corresponding bulk materials is applied. Biopersistent high
aspect ratio (HAR) ENMs are defined as ENMs with an aspect
ratio less than 3:1, a length greater than 5 μm, a diameter less
than 3 μm, and an aqueous dissolution rate (suggesting bioper-
sistence) greater than 100 mg/L or a pulmonary half-life upon
intratracheal instillation greater than or equal to 40 days.
Passive ENMs are those materials considered to be of very low
or no hazard potential by virtue of containing less than 0.1%
toxic components, low surface reactivity (e.g., based on ferric
reducing ability of serum or cytochrome C), high dispersibility
(based on an average aggregation number (AAN) ≥ 3), no cellu-
lar effects observed at a surface area ≤10 µg/cm2, and low toxic
potency (i.e., a no adverse effect concentration (NOAEC) in
short-term inhalation studies (STIS) >10 mg/m3). Active ENMs
are those that either do not meet the criteria for soluble ENMs,
biopersistent high aspect ratio ENMs, or passive ENMs, or that
meet the criteria for multiple categories, assuming that the
NOAEC for the ENM in STIS is ≥610 mg/m3. For ENMs of
group 4, further sub-grouping is required according to the
degree of mobility in air (dustiness) and in physiological fluids
(dispersibility), as well as on the uptake, biopersistence, and
biodistribution as determined in vitro and in vivo short term
inhalation studies (STIS).
The DF4Nano Grouping is based on data provided by the
analyst for the ENMs of interest through “tiers” or information
filters, where specific thresholds are set for intrinsic material
properties (e.g., water solubility, primary particle size, surface
area, composition, crystallinity, and surface chemistry); system-
dependent properties (e.g., dissolution rate in biological simula-
tion fluid (BSF), release of toxic ions, size in relevant media
and dispersibility); biopersistence (e.g., property of the ENM to
persist in a cell, tissue, organ or organism as a proxy of pulmo-
nary retention); uptake and biodistribution (e.g., evidence of
alveolar uptake and subsequent distribution through the pulmo-
nary system); and cellular (e.g., membrane damage including
cationic phagolysosome damage, generation of reactive oxygen
species (ROS), oxidative stress, redox activities, etc.) and apical
toxic effects (e.g., respiratory effects shown in short-term
inhalation studies).
The initial tier (0) focuses on gathering data regarding intrinsic
material properties (e.g., water solubility, primary particle size
(PPS), surface area, composition, crystallinity, and surface
chemistry). In tier 1, the ENM can be assigned into one of the
following groups of intrinsic material properties: water solu-
bility, particle morphology (PPS and shape, including aspect
ratio and surface area) and chemical composition. Tier 2
focuses on the ENM’s i) intrinsic properties and those linked to
the ENMs functionality in the environment, (e.g., surface reac-
tivity, dissolution rate, and dispersibility), ii) intended use,
release and exposure, iii) uptake, biodistribution and biopersis-
tence, and iv) biophysical interactions and cellular effects [36]
to assign non-soluble ENMs to one of the following groups:
biopersistent high aspect ratio (HAR) ENMs, passive ENMs, or
active ENMs. Analysis within tier 2 is meant to indicate
whether the ENM should be classified as either a biopersistent
HAR ENM or an active ENM. Tier 3 is reached if the ENM has
not been classified within any of the groups of tiers (1) and (2)
or to confirm/revise the assignment of ENMs to the resulting
category. Tier 3 includes a confirmation of in vivo toxic effects,
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which are considered higher in ranking than in vitro effects, to
define and refine additional information needs. The specific
toxicological information assessed in tier 3 includes: lung
burden, systemic uptake, in vivo biopersistence, biodistribution,
apical toxic effects and toxic potency, as assessed by STIS, in
addition to ex vivo genotoxicity screening.
The application of the DF4Nano Grouping has been proposed
[36] as a resource where physicochemical characterization and
toxicity data are available for the ENM under consideration, or
for those ENMs with similar properties to those for which toxi-
cological information is available. In cases involving novel
ENMs or where physicochemical characterization data are
lacking, the application of DF4Nano requires additional ENM
characterization. Also, given that exposure assessment is not
performed in this framework the applicability of DF4Nano is
suitable where qualitative assessments may suffice.
A modified GreenScreen tool [65] was recently developed
[37] following the original GreenScreen approach advanced by
the Clean Production Action Group to assist in conducting
chemical hazard assessment. The approach incorporates aspects
of the US EPA’s Design for the Environment (DfE) Alterna-
tives Assessment Criteria for Hazard Evaluation and the Glob-
ally Harmonized System (GHS) of Classification and Labelling
of Chemicals [37,65]. GreenScreen was modified for applica-
tion to ENMs by including collection of physicochemical prop-
erties of the target nanomaterials (e.g., agglomeration and or
aggregation, chemical composition, purity, shape, surface area,
surface chemistry (including composition and reactivity)) [37].
The various studies from which information on the nanomateri-
als (properties and toxicity endpoints) is compiled are then
assessed with respect to the reliability of the provided informa-
tion. Briefly, the application of the modified GreenScreen ap-
proach, which is available as an online software tool, entails the
following steps:
1. collection of publicly available data for 18 parameters
that are relevant to hazard outcome (both chronic and
acute) associated with the hazard endpoints of the target
chemical,
2. expert evaluation of the collected data to assign
“Benchmark Scores” (e.g., low, medium or high
concern) or “DG” for data gaps to each of those 18
hazard endpoints;
3. assigning an aggregated benchmark (BM) score to
categorize recommendations with respect to the material
use.
The proposed five categories are as follows: BM1 is for a
substance of very high concern as defined by U.S., Canadian
and European regulatory bodies, BM2 and BM3 designate a
material that can be continued to be used but safer substitutes
are desirables as the nanomaterial may present human health
concerns, BM4 is for a material that represent low hazards to
humans and the environment, and a fifth category (BM-U)
where information is insufficient to assign a score.
In a case study developed by Sass et al. [37], two types of nano-
sized Silver, AGS-20 and low soluble nano-Silver, were com-
pared to non-nano Silver (conventional Silver). Analysis using
the modified GreenScreen tool suggested that low soluble nano-
Silver and conventional Silver were of category BM-1 given ev-
idence of high persistence and high ecotoxicity. In contrast, the
lack of data for AGS-20 suggested classification of BM-U. As
the above study notes [37], the modified GreenScreen tool is
not intended for quantitative risk assessment, but rather as a
suitable means for rapid screening to identify data needs and to
compare available hazard information for ENMs.
Frameworks for characterization of environ-
mental risk
In evaluating frameworks that were designed to explicitly assess
both hazard and exposure potential and to yield a net measure
of risk potential, the present review focused on first consid-
ering frameworks that were designed to characterize environ-
mental risk (including risks to humans due to environmental
multimedia exposures) and then those designed to characterize
occupational risk. Nine different frameworks for characteriza-
tion of environmental risk of ENMs were assessed: (a) Life
Cycle Analysis, (b) DuPont’s Nano Risk Framework, (c) the US
EPA’s Comprehensive Environmental Assessment (CEA)
Framework, (d) NanoHAZ, (e) Nanomaterial risk screening tool
(NRST), (f) the Engineered Nanoparticles – Review of Health
and Environmental Safety: Human Health and Ecological Risk
Assessment (ENRHES RA), (g) Risk Quantification based on
Probabilistic Mass Flow Analysis (PMFA risk quantification),
(h) Forecasting of the Impacts of Nanomaterials in the Environ-
ment (FINE) based on Bayesian Networks (BN), and (i) Life
Cycle Risk Analysis for Nanomaterials (Nano LCRA).
(a) Life Cycle Analysis (LCA) refers to a class of approaches
that follow a product over its life stages, including: (a) material
acquisition and purification, (b) manufacturing and fabrication,
(b) commercial uses, and (d) end-of-life product management
[66]. LCA is rooted in assessing environmental impacts. Exam-
ples of impacts that have been assessed previously using LCA
include climate change, smog creation, eutrophication, toxico-
logical stress on human health and ecosystems, depletion of
resources that occur as a consequence of releases into the envi-
ronment, and consumption of resources [67]. According to the
Society of Environmental Toxicology and Chemistry (SETAC),
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LCA consists of the following steps: i) goal scope and defini-
tion (e.g., establishment of the product under analysis and study
objectives); ii) life cycle inventory analysis (e.g., tabulation of
emissions and consumption of resources at each life stage of the
product); iii) life cycle impact assessment (e.g., assessment of
the impacts at each life stage of the product, which depend on
the scope of the LCA); and iv) life cycle improvement assess-
ment (e.g., a review of the LCA results to reduce impacts
related to the product under analysis) [67].
The applicability of LCA to assess the environmental impacts
of ENMs has been the subject of different reviews [39,40,68],
and the integration of LCA with risk assessment has also been
suggested as a tool that could inform the development of nano-
enabled products that are “safer by design” [5]. For example,
Grieger et al. [68] qualitatively analyzed published case studies
of ENMs RA and LCA. Their analysis demonstrated the differ-
ences between these two approaches: LCA provides an assess-
ment of environmental impacts of a product/system while RA
provides an assessment a particular substance or component of
a complex material. Hischier et al. [40] reviewed LCA case
studies of several ENMs (e.g., CNTs, single walled CNTs, ful-
lerenes, quantum dots and TiO2) and nano-enabled products
(e.g., dye containing nano-TiO2 and carbon powder, t-shirt with
nano Ag coating, and polymer composite) to assess the poten-
tial contributions of material production to CO2 emissions.
Most of the reviewed studies focused primarily on inventory of
CO2 emissions or energy analysis [40]. An exception was a
partial LCA and aquatic ecotoxicity impact assessment of car-
bon nanotubes (CNTs) reported by Eckelman et al. [38]. This
latter study compared the environmental impacts (in freshwater)
of chemical releases resulting from the manufacture (e.g., arc
ablation, chemical vapor deposition (CVD), and high-pressure
carbon monoxide (HiPco)) for a hypothetical scenario in which
CNTs and chemical releases are associated with the production
of CNTs. The environmental impact of CNTs was quantified
via a characterization factor (i.e., CF = effect factor × fate factor
× exposure factor) calculated as per the methodology of the fate
and transport module of the USEtox model [69]. The aquatic
environmental impact of the release of chemicals released to
freshwater due to CNT manufacturing was assessed based on
previously reported data [70] and LCA software (Sima Pro 7.3)
[38]. In the above approach, the effect factor was defined as the
ratio of the potentially affected fraction (PAF) of aquatic organ-
isms and average EC50’s for the evaluated aquatic species. The
fate was quantified as the residence time (days) of the CNTs or
related chemicals in freshwater expressed as per the USEtox
model. Here it is emphasized that USEtox was not developed to
specifically describe the fate and transport of particles or parti-
cle-bound chemicals; thus, its extended application to ENMs
was based on heuristic assumptions and approximations. In the
presented case studies, two different hypothetical release
scenarios were considered for two hypothetical cases in which
either 100% (“worst case”) or 2% of the total produced CNTs
were assumed to be released to freshwater. It was concluded
that under the “worst case” scenario the expected environ-
mental impacts of CNTs would be equivalent to that which
would result from chemicals released to the environment during
the manufacture of CNTs. However, under the 2% release
scenario, the expected environmental impacts of CNTs were
assessed to be several orders of magnitude lower than for chem-
icals released during the manufacture of CNTs. Hence, further
research was recommended for the purpose of developing safer
manufacturing processes for CNTs [38]. It is important to note
that LCA offers a myriad of options for analyses of ENMs that
have to be considered on a case-by-case basis. Depending on
the scope of the assessment when sufficient data are available
regarding ENM properties, fate and transport parameters, emis-
sions, and toxicity/hazard then LCA could be performed to a
reasonably approximate level via the USEtox model. The
results of such analysis must be evaluated cautiously given that
USEtox is a model designed for dealing with organic chemicals
and does not consider the complex environmental fate and
transport behavior and toxicity of ENMs.
(b) DuPont’s NanoRisk Framework, developed based on a
joint effort by the Environmental Defense Fund and DuPont
[41], is a guide to presenting questions and request for informa-
tion that should be considered by an organization to evaluate the
risks associated with specific ENM applications. NanoRisk is a
qualitative framework that guides the development of informa-
tional profiles (e.g., properties, hazards and exposures associat-
ed with a nanomaterial and its application) for the target ENMs
throughout their lifecycle. The output is a worksheet that
includes information on:
1. material description and application (e.g., technical
name, commercial name, common form),
2. ENM Profile Lifecycle(s) which consists of ENM Life-
cycle Properties (ELP), ENM Lifecycle Hazard, and
ENM Lifecycle Exposure (ELE) Profiles.
The NanoRisk ELP Profile includes ENM physicochemical
properties such as chemical composition, surface coating, mo-
lecular structure, crystal structure, physical, form/shape, parti-
cle size, size distribution and surface area, agglomeration state,
particle density, ENM bulk density, porosity, dispersibility,
solubility in water and biologically relevant fluids, surface
charge, and surface reactivity. The ELH profile includes acute
hazard/toxicity information for the target ENM, and the ELE
profile focuses on workers’ exposure to ENM during the indus-
trial process.
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NanoRisk is useful in guiding the analyst in gathering informa-
tion needed to assess the potential risk associated with the ENM
of interest following the Chemical Process Quantitative Risk
Assessment (CPQRA) approach [71]. CPQRA is a methodolo-
gy applied in the chemical, petrochemical and oil processing
industries to evaluate the overall process safety rather than a
specific chemical substance or ENM [71]. CPQRA consists of
six steps:
1. definition of potential incidents (e.g., qualitative hazard
analysis),
2. evaluation of potential consequences of the incidents
(e.g., via vapor dispersion modeling and fire and explo-
sion effect modeling),
3. estimation of the potential incident frequencies (e.g., via
databases),
4. estimation of the incident impacts on people, environ-
ment and property,
5. estimation of the risk (e.g., combination of the potential
consequences for each incident with the incident fre-
quency and summing over all events), and
6. evaluation of the risk (e.g., identify the major sources of
risk and determination if there are cost-effective process
or modifications to reduce risk).
NanoRisk itself does not generate specific guidance regarding
quantitative estimation of risk associated with ENMs and does
not provide a stand-alone methodology for integrating quantita-
tive and qualitative information related to risk potential. How-
ever, NanoRisk does document a series of possible risk manage-
ment decisions that should be addressed and provides recom-
mendation on how to document specific risk management
options.
(c) The US EPA’s Comprehensive Environmental Assess-
ment (CEA) Framework provides a high-level set of recom-
mendations for approaching the subject of assessing the poten-
tial health and environmental impacts of nanomaterials [42].
CEA recommends following a traditional risk assessment
process [18], but stresses the need for considering the complete
product lifecycle, transport and transformation in the environ-
ment, and exposure potential or absorbed dose (by all exposure
pathways), in addition to impact assessment. CEA recommends
the construction of an information system that considers both an
expert domain knowledge (including via meta-analysis) and
utilization of various LCA methods, cost-benefit analysis, and
decision science methods, while engaging stakeholders in the
CEA process. CEA was evaluated via a case study [43] in
which stakeholder engagement (expert elicitation) served to
collect information about the risk potential of using multi-
walled carbon nanotubes (MWCNTs) in flame-retardant coat-
ings in upholstery textiles. Expert opinions were elicited, via a
web-based tool (“CEAWeb”) [43] to prioritize the range of
needed studies on MWCNT release across the product life cycle
and human exposure or health impacts, which included, for ex-
ample, defining/quantifying exposure scenarios, effects of
MWCNT functionalization, developing techniques to quantify
MWCNTs in air and other media, and estimation of safety
thresholds [43]. CEA case studies were also documented for
Nano Ag and Nano TiO2, in which information gaps were
assessed to identify future research needs and priorities [72].
Overall, although CEA provides a useful roadmap for evalu-
ating the potential impacts of ENMs, this “framework” is essen-
tially a guidance document that falls short of providing or
recommending specific quantitative methodologies for the inte-
gration and analysis of information/data to assess the risk poten-
tial of ENMs.
(d) NanoHAZ is an approach developed specifically for
assessing the potential ecological risks associated with ENMs
(including human risks associated with exposure to ENMs
through environmental media) in Ireland [44]. NanoHAZ is
based on comparison of estimated ENMs concentrations with
existing regulatory limits for specific ENMs or their chemical
building blocks [44]. The approach relies on probabilistic mate-
rial flow analysis (MFA) with heuristics or assumptions based
on empirical knowledge regarding the potential ENM exposure
concentrations in the various media. The estimated exposure
level in a given media (primarily air and water) for the target
ENM is then compared to a bench-mark exposure concentra-
tion or critical concentration at which a specific effect is ob-
served (as determined from in vivo toxicological studies) for the
target receptors (human or ecological). One limitation of the
NanoHAZ approach is the paucity of regulatory limits for
ENMs [44]. As a result, the initial reported application of the
approach, which focused on metal and metal oxide ENMs,
utilized regulatory limits on exposure concentrations for dis-
solved metals or chemical building blocks of the ENMs as
surrogates for the ENMs themselves [44]. Specific NanoHAZ
case studies were reported for nano TiO2 in paints, nano Ag as
an antimicrobial agent in food packaging, and nano CeO2 as a
fuel additive. It was concluded that the level of concern
regarding inhalation exposure to airborne nano CeO2, associat-
ed with its use as a fuel additive, was higher relative to concern
regarding air releases of nano Ag and nano TiO2. The level of
concern for nano TiO2 was considered moderate given its rela-
tive high score of potential exposure in drinking and surface
(relative to nano-Ag and nano-CeO2), and low relative score of
hazard (e.g., ecotoxicological and toxicological effects) com-
pared to nano-Ag. Finally, nano-Ag as an antimicrobial agent in
food packaging was considered of low concern given its low
score for potential exposure (lower release expected in water
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compared to nano-TiO2) despite its moderate and high scores
for ecotoxicological and toxicological effects.
Overall, the application of NanoHAZ can be useful if informa-
tion is available regarding environmental releases of ENMs and
their potential toxic effects are known or can be predicted from
suitable models. As described in the available case study [44]
NanoHAZ can serve to compare and rank ENMs with regard to
their potential exposure and hazard.
(e) The Nanomaterial risk-screening tool (NRST) was de-
veloped on the basis of expert opinions compiled at a nanotech-
nology workshop that focused on assessing the importance of
various factors that may affect hazard, exposure and risk associ-
ated with ENMs. The framework was formulated as an excel
spreadsheet in which the analyst can select qualitative “risk
ratings” (scale of 1–5, where 1 represents the lowest concern)
[45]. The hazard rating is then calculated as the linear aggrega-
tion (using weight factors) of scores assigned to each contribut-
ing ENM physicochemical attribute (e.g., ENM chemical com-
position, crystallinity, average size, aspect ratio, surface area
and charge, reactivity, solubility, hydrophobicity, agglomera-
tion and sorption tendency) and contributing ENM hazard indi-
cators (e.g., ENM potential for inducing ROS and mobility
through cells). The exposure rating is determined based on
aggregation of individual scores assigned to factors linked to
environmental and human exposure potential during product
manufacturing, use and end-of-life. These factors include prod-
uct characteristics (e.g., content of ENM in product and form,
product type) and exposure indicators (e.g., ENM environ-
mental release potential, frequency and duration of exposure,
number of exposed individuals). The aggregation of scores
follows an assumption of linear additivity with assumed weight
factors. It is noted that the aggregation approach does not
provide for the establishment of bi-directional cause-effect rela-
tionship pathways. Therefore, one cannot directly ascertain the
reliability of the obtained ranking relative to the existing quanti-
tative body of evidence. Overall, however, the approach is a
useful first step in organizing information and opinions to arrive
at an initial ranking of concerns as being high, medium or low.
(f) Engineered Nanoparticles – Review of Health and Envi-
ronmental Safety: Human Health and Ecological Risk
Assessment (ENRHES RA) is a framework developed as part
of the European Union project “Engineered Nanoparticles:
Review of Health and Environmental Safety (ENRHES)” [46].
The goal of ENRHES is to facilitate estimation of ecological
and human health impacts of ENMs and identification of data
gaps for regulatory risk assessment under the European REACH
(Registration, Evaluation, Authorization and Restriction of
Chemicals) guidelines [46]. While the focus on human risk
assessment presented in the published case studies [46] is not
occupational, the exposure profiles reviewed included human
exposure via manufacturing, consumer products and contact
with the environment. The first step of the analysis process
entails hazard identification (e.g., obtaining indicative no effect
concentrations (INEC) for ecological receptors and indicative of
no effect levels (INELs) for human population from published
data) [73-76]. The second step consists of exposure assessment,
performed on the basis of evaluating the occupational exposure
for human receptors reported in the literature for the target
ENM(s). Environmental exposures are qualitatively estimated
using the expected or known ENM presence in environmental
compartments based on estimates obtained from material flow
analysis (MFA) [77]. It is noted that the MFA data, incorporat-
ed into the ENRHES RA, are not based on fundamental
modeling of multimedia fate and transport. Thus, it is possible
for mass balance inconsistencies to arise and violations of
constraints imposed by intermedia transport mechanisms. The
third step consists of risk characterization for human and eco-
logical receptors. For human risk characterization, the measured
and/or monitored occupational exposure concentrations were
compared with the INELs, whereas for ecological risk assess-
ment the modeled ENMs concentrations (e.g., orders of magni-
tude ng/L, µg/L, µg/m3) were compared with the INEC values.
ENRHES RA was demonstrated in a case study [46] exploring
the potential human risk of four ENMs (nano-Ag, nano-TiO2,
nano-ZnO, fullerenes and carbon nanotubes (CNTs). The analy-
sis revealed that the INELs of fullerenes, nano-Ag and nano-
TiO2 are lower than most of the reported occupational exposure
concentrations for these materials. It was also suggested that the
exposure concentrations of concern, for ecological receptors,
are likely to be due to release of the ENMs into water in the
following decreasing level of concern: ZnO >> Nano-Ag >>
Nano-TiO2 > (MWCNT=C60) [46].
In summary, the application of ENRHES RA framework for
ENMs is particularly useful as a roadmap for the REACH
process. While the approach provides a conceptual based de-
scription of the analysis process, as illustrated by case studies,
application of the ENRHES RA framework is at present limited
by the availability of exposure and hazard information for the
target ENMs.
(g) Risk Quantification Based on Probabilistic Mass Flow
Analysis (PMFA risk Quantification) was proposed as a basis
for risk-based classification system of ENMs present in water
and soils with the goal of quantifying the probability of environ-
mental risks [47,78]. The approach relies on a probabilistic ma-
terial-flow analysis (PMFA) [78] to estimate the releases of
ENMs to the environment on the basis of available data and
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expert judgement regarding production, use and disposal, along
with heuristic and empirical assumptions to arrive at potential
exposure concentrations in various media [79]. Published toxic-
ity data (e.g., terrestrial and aquatic species tested for no ob-
served effect concentrations, lowest observed effect concentra-
tions and lethal concentrations for a 50% of the population) are
used as inputs. The above compiled information is then used to
build species sensitivity distribution (SSD) models [80]. SSD
models have also been used by the US EPA to summarize evi-
dence for stressor-response relationships obtained from labora-
tory studies [81]. In such an approach, the risk probability
metric is defined as the product of the probability distribution of
the predicted environmental concentrations and the probability
that one or more organisms would be negatively impacted as a
function of environmental concentration. In such analysis, zero
percent risk indicates that all predicted environmental concen-
trations are lower than the lowest limit of the probabilistic SSD,
and a 100% risk means that all predicted environmental concen-
trations overlap with the probabilistic SSD. Using this ap-
proach, Gottschalk et al. [47] evaluated the relative environ-
mental risk posed by selected ENMs in Switzerland. It was re-
ported that the highest risk, due to releases from sewage treat-
ment plants, was associated with nano-Ag (40% overlap of the
modeled environmental concentrations with the SSD for aquat-
ic species), followed by nano-TiO2 (19% overlap) and nano-
ZnO (1% overlap). With regard to ENMs found in surface
water, nano-Ag was reported to present a higher risk (1%
overlap) than nano-TiO2 (<0.1% overlap). In contrast, the
authors concluded that there was no measurable risk related to
CNTs and fullerenes in any of the studied environmental com-
partments (e.g., water and soil) [47].
The PMFA framework is useful if quantitative data/information
are available to construct the SSD and to estimate environ-
mental concentrations. However, the application of the PMFA
framework also requires expertise to conduct the analysis and
reliance on expert judgement in estimating exposure concentra-
tions and the SSD.
(h) Forecasting of the Impacts of Nanomaterials in the Envi-
ronment (FINE) Based on Bayesian Networks (BN) is an ap-
proach proposed to formally incorporate expert judgments to
address data gaps and provide a probabilistic measure of poten-
tial environmental impacts of ENMs [48]. The above approach
is suitable for both incremental learning and propagation of
uncertainties [82]. The initial demonstration of this method was
an assessment of the environmental impacts of nano-Ag in
water and sediment [48]. BN were used to integrate quantita-
tive and qualitative information, address data gaps, quantify
uncertainties, and provide bidirectional causal relationships.
Briefly, the BN approach consists of two main parts: 1) devel-
opment of the network structure (nodes and their connectivity),
and 2) determination of baseline parameters for each node in the
form of conditional probability tables (CPTs). In the test study
reported for nano-AG [48], the BN structure was developed on
the basis of expert elicitation and consisted of nodes that were
grouped into three categories: i) media parameters (e.g., temper-
ature, pH, presence of organic matter), ENM properties (e.g.,
ENM coatings, zeta potential, fractal dimension, ENM diame-
ter) and ENM transformations (e.g., ENM aggregation poten-
tial, attachment efficiency, biodegradation, dissolution and
deposition); ii) exposure potential (e.g., ENM concentration
entering system, concentration in sediment, water and dis-
solved concentration), and iii) hazard potential (e.g., bioavail-
ability potential, biouptake, effects on biomass/mortality,
effects on the ecosystem, such as decomposition, methanogen-
esis, eutrophication). In the case study reported by Money et al.
[48], the CPT for the different nodes and individual variables
(input values, units, ranges and categories) were established
based on expert judgment, and the BN was applied to estimate
ecological risks (e.g., probability distribution of risk being <1 or
>=1) posed by nano-Ag particles present in the aquatic environ-
ment. The case study suggested that the greatest potential risk is
expected when nano-Ag is accumulated in sediments rather than
in water [48]. Given that the FINE BN framework was tailored
specifically for nano-Ag in water, its applications is relevant to
the aquatic environment. However, it is stressed that FINE BN
can be tailored to different ENMs, and various environmental
media, provided that the BN design includes the causal relation-
ships governing the various aspects of the environmental fate
and transport and toxicity behavior of the classes of ENMs
under consideration. The FINE BN framework can be particu-
larly useful for integrating quantitative and qualitative informa-
tion and for enabling periodic updates (i.e., as new data
becomes available) via incremental learning.
(i) Life Cycle Risk Analysis for Nanomaterials (Nano
LCRA) is a screening approach developed with the intent of
identifying potential risks and data gaps over a nanoproduct’s
life cycle [49,55]. Nano LCRA incorporates relevant data
through the life cycle of the target ENM with the intent of
informing risk management practices and prioritizing research
strategies. The analysis consists of the following steps:
1. Description of the life cycle of the product;
2. Identification of the materials and assessment of the
potential hazards in each life cycle stage;
3. Exposure assessment for each life cycle stage;
4. Identification of the life cycle sages in which exposure
may occur;
5. Evaluation of potential human and nonhuman toxicity at
the key life cycle stages;
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6. Analysis of risk potential for selected life cycle stages;
7. Identification of key uncertainties and data gaps and
communication of findings;
8. Development of mitigation/risk-management strategies;
9. Gathering additional information (e.g., data that might
have been identified as missing from the assessment);
10. Evaluating the efficiency of the developed risk manage-
ment strategies and identifying the next set of priorities
(e.g., identify newly available data to update mitigation/
risk-management strategies) [49].
The Nano LCRA framework was applied to assess the potential
risks of using cellulose nanomaterials (CNs) as substitutes for
resource-intensive materials, such as plastics, including those
used in commercial applications (e.g., packaging, composite
polymers, paints, cosmetics, water and air filtration, and recyc-
lable electronics), and to identify data gaps [50]. Case study
results indicated that the highest priority for the development of
new data is the need for information/data regarding occupa-
tional inhalation exposure associated with handling CNs as a
dry powder. The authors also concluded that there is a signifi-
cant knowledge gap regarding the toxicity of CNs used in con-
sumer products, such as packaging.
The Nano LCRA framework appears to be useful for qualita-
tive analysis. However, the available studies have not incorpo-
rated a method for integration of quantitative data (e.g., release
amounts of ENMs to the environment, predicted/calculated
environmental concentrations, toxicity thresholds, etc.) Evalua-
tion of the reported LCRA case study suggests that use of the
Nano LCRA framework would require extensive data collec-
tion and analysis expertise throughout the various steps.
Frameworks for risk characterization in
occupational settings
In general, the proposed frameworks to characterize risks in
occupational settings reflect efforts to adapt existing environ-
mental RA approaches for conventional chemicals to develop
and implement effective risk management (RM) guidance for
addressing the risks of occupational exposures to ENMs [51].
Four different frameworks for characterizing the occupational
risks of ENMs were evaluated: (a) the Risk-Based Classifica-
tion for Occupational Exposure Control (“Risk-Based OEL”)
approach, (b) the Risk Classification Based on an Industry
Insurance Protocol (RCIP) approach, (c) CB Nanotool, and
(d) the Web-Based Tool for Risk Prioritization of Airborne
Manufactured Nano Objects (“Stoffenmanager Nano”).
(a) The Risk-Based Classification for Occupational Expo-
sure Control (“Risk-Based OEC”) approach was proposed to
facilitate the development of occupational exposure levels
(OELs) to improve risk management (reduce workers’ expo-
sure) in the workplace [51,83]. In the Risk-Based OEC ap-
proach, hazard of ENMs are evaluated and risk estimates (e.g.,
% of excess risk) are developed. In cases where limited hazard
data are available for the ENMs, hazard data for reference
(benchmark) materials are used. Reference materials are
selected based on whether they exhibit similar chemical/materi-
als properties and similar modes of action (MoA) to the ENM
of interest (e.g., for nano-TiO2, data for fine and ultrafine TiO2
were used). Examples of modes of action include ROS forma-
tion, genotoxicity, or interference with specific cellular func-
tions. The risk potential for exposure to the new ENM(s) in
occupational settings via inhalation is then systematically com-
pared with those of benchmark material(s) in the same MoA
class. For example, Kuempel et al. [51] used the approach to
assess the risk potential of exposure to a variety of airborne par-
ticles, including both fine and ultrafine materials. The following
standard risk assessment process steps were followed [18]:
1. Identifying the relevant animal model, dose metric, and
disease response;
2. Modeling the animal dose–response relationship and
estimate the critical effect level (e.g., benchmark dose);
3. Extrapolating the animal critical effect level estimates to
humans by adjusting for factors that influence the
deposited or retained lung dose in each species,
assuming equal response at equivalent dose;
4. Estimating airborne exposures (8 h time weighted aver-
age (TWA)) that would result in the human-equivalent
dose.
The authors then calculated the 1/1,000 excess risk of lung
cancer based on animal-to human extrapolation of benchmark
dose estimates (“BMD” is a dose associated with a specified
increase in the probability of a given response known as the
“benchmark response” (BMR)) using a multistage cancer model
and the US EPA’s BMD software [84]. Four risk categories
were established in the above case study, for ENMs and fine-
sized particles in air based on information derived from previ-
ously reviewed control approaches [85]:
1. Low Risk bin/category aimed at dusts at an airborne con-
centration range >1 mg/m3 and where exposure can be
controlled with general ventilation measures (e.g., fine-
sized particles TiO2 and MoO3 at concentrations in the
range of 1,000–4,000 µg/m3 TWA;
2. Moderate Risk bin for dusts at an airborne concentration
range (0.1–1 mg/m3), which can be controlled with local
exhaust ventilation measures; (e.g., carbon black, diesel
exhaust particulate (DEP), and ultrafine TiO2 at TWA
airborne concentration (90–250 µg/m3);
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3. High Risk categories for dusts at an airborne concentra-
tion range (0.01–0.1 mg/m3), which can be controlled
through ventilated enclosures; (e.g., fine particles of NiO
and soluble CoSO4 at TWA 20–30 µg/m3);
4. Very High Risk (dusts at airborne concentrations
0.001–0.01 mg/m3), which can be controlled with
containment systems (e.g., fine particles Ni3S2 and GaAs
at TWA 4–5 µg/m3).
The above Risk-Based OEC is useful for grouping inhalable
ENMs in occupational settings on the basis of workers’ expo-
sure to ENMs or their ultrafine counterparts. However, consid-
erations of the latter also require adequate characterization and
toxicity/hazard data.
(b) The Risk Classification Based on an Industry Insurance
Protocol (RCIP) was designed to compare risks associated
with specific steps in the manufacturing of ENMs (as opposed
to overall occupational risk) with those of traditional chemicals
used in current activities such as petroleum refining, polyeth-
ylene production, and synthetic pharmaceutical production [52].
This framework follows two major parts. The first part involves
data collection for each of the steps of a particular manufac-
turing/synthesis process including, inventory of input or
constituent materials, output materials, waste streams, and phys-
ical conditions of the manufacturing processes (e.g., tempera-
ture, pressure and enthalpy, if available, or representative syn-
thesis methods including a full description of the processes in
form of flowcharts). For each constituent material the data to be
collected include: toxicity values (e.g., LC50 and/or LD50),
water solubility, octanol–water partition coefficient, flamma-
bility, expected emissions, molecular weight, and photolysis
and degradation rates (e.g., photolysis and degradation rates are
considered to predict mobility of a material). In the second part
of the framework an actuarial tool (“XL tool”) is used to assign
and tabulate risk scores to the operating conditions of the chem-
ical processes, as well as to hazardous properties and toxicity
values of the constituent materials.
The XL tool follows a protocol that is routinely used by
industry to calculate insurance premiums. In the RCIP frame-
work, the XL analysis involves a series of arithmetic operations
to calculate additive scores for the “risk” posed by a specific
process, the “risk” posed by the hazard/toxicity of the
constituent materials, and the “risk” posed by the amount of the
material emitted. After additive scores for the individual param-
eters inventoried in step (1) are obtained, an aggregated score is
calculated (e.g., the sum of the “risk” posed by the process, the
“risk” posed by the hazard/toxicity of the constituent materials
and the “risk” posed by the amount of the material emitted).
The aggregated score is calculated considering two scenarios:
a) normal conditions of operation (e.g., assuming that none of
the constituent materials are mobile and that photolysis and
degradation do not occur); and b) an accident scenario (to
account for what might occur if there was an accidental emis-
sion resulting in mobility of the constituent materials/chemi-
cals); photolysis and degradation rates are also considered along
with process conditions (e.g., temperature, pressure and heat
transfer). These two aggregated scores, for the normal condi-
tions and accident scenarios are then added and normalized with
respect to the highest score to yield an overall score, which is
referred to as the latent risk score.
The above approach was demonstrated by Robichaud et al. [52],
for a case study that considered representative synthetic
processes for selected ENMs (C60, single-walled carbon
nanotubes (SWCNT), multi-walled carbon nanotubes
(MWCNT), cadmium selenide (CdSe) and zinc selenide (ZnSe)
quantum dots, carbon black, aluminum and silver nanoparticles
(nano-Al and nano-Ag)) that were compared to synthetic pro-
cesses for traditional chemicals (petroleum refining, polyeth-
ylene production, and synthetic pharmaceutical production).
The analysis suggested that the manufacturing of the ENMs
studied might present lower risks than for the chemicals listed
above.
(c) The Control Banding (CB) Nanotool [53] is an approach de-
veloped with the intent of identifying/prioritizing health risks in
the workplace in order to assist in the implementation of expo-
sure controls [53]. Control banding is a term originated from the
field of industrial hygiene [53] and represents a qualitative ap-
proach to assessing risks associated with chemicals with the
goal of developing suitable control measures (e.g., via personal
protective equipment, administrative or engineering controls).
In CB Nanotool, categories or ‘‘bands’’ are established for
health hazards of ENMs, which are then combined with expo-
sure scenarios for the target ENMs, to determine recommended
levels of control. An advantage of this approach is that it can be
used even in the absence of toxicity data for the specific ENM
of interest. The above is regarded as a practical approach in the
field of ENMs occupational risk management, given the need to
provide recommendations for control measures in the absence
of complete hazard profiles for the rapidly growing number of
new ENMs [53].
The CB Nanotool [53] was designed specifically for inhaled
ENMs to determine the level of risk of operations carried out in
research laboratories. In this approach, the risk level band is
assigned based on a matrix that combines two scores, one for
severity (e.g., degree of biological response elicited by the
ENM exposure via inhalation or presence in the bloodstream)
and one for probability (e.g., the extent to which employees
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may be potentially exposed to ENMs throughout the handling
processes). The severity score is calculated by adding indi-
vidual scores (e.g., scores assigned via the guidelines recom-
mended by the authors) for physicochemical properties of the
ENM (e.g., surface chemistry, particle shape, particle diameter,
solubility) and evidence of toxicity (e.g., reproductive, carcino-
genic, mutagenicity, dermal and acute toxicity) available for the
ENM and for the ENM bulk counterpart (main chemical
substance in the composition of the ENM). A probability score
is calculated by adding individual scores assigned to the esti-
mated amount of handled ENM (i.e., by the worker), dustiness/
mistiness, number of employees with similar exposure, and
duration of operation. Similar to the severity score, the pro-
posed approach provides guidelines for assignment of values to
each of the parameters of the probability score. The final prod-
uct is presented as a combined score of the severity and proba-
bility parameters which are assigned to control bands. The
combined score or assignation to a control band (e.g., RL) is
done qualitatively via a matrix in which the severity scores of
low, medium, high and very high grouped by category as rows,
while the probability scores of extremely high, less likely, likely
and probable grouped by category as columns. For example, the
box assigned to the combination of the highest probability score
with the highest score of severity will result in the highest band
of recommended control measures (e.g., Risk Level 4 (RL 4),
“seek specialist advice”). As the combination of scores
decreases in value, the assigned bands correspond to lower
recommended control measures. An EXCEL sheet for use with
the above approach was reported by Paik et al. [53] and later
evaluated by Zalk et al. [86].
The CB Nanotool represents a framework that is useful for
identifying potential control measures for workers’ protection.
Its utility, however, is predicated on the availability of informa-
tion on the various activities/steps (e.g., handling ENMs in
powder form) involved in the ENM manufacturing process, as
well as the hazards posed by the ENMs.
(d) The Web-Based Tool for Risk Prioritization of Airborne
Manufactured Nano Objects (“Stoffenmanager Nano”) [54]
is a framework based on control banding, similar to the CB
Nanotool. The Stoffenmanager Nano approach aims at identi-
fying control measures to reduce the likelihood of inhalation
exposure in occupational settings. This framework requires both
exposure and industrial process information (e.g., point or fugi-
tive emissions during production, handling powdered ENMs,
dispersion of ENMs and activities resulting in ENM release,
such as sanding of surfaces) and hazard identification parame-
ters (e.g., solubility of ENMs, nanofiber shape, toxicological
data of the ENM or parent material) as inputs. The approach is
divided into two steps: 1) an assignment of a hazard category
for the ENM and 2) an assignment of an exposure category for
the industrial process.
In the first step, one of five hazard categories (A–E, where A
and E represent the lowest and highest hazards, respectively) is
assigned based on available data. For example, hazard classifi-
cation can be made based on the water solubility of the ENM
(i.e., high water solubility would suggests lower hazard as an
ENM and thus such ENM would be in category (A) or based on
persistence of nanofibers (where persistent nanofibers would
result in a high hazard category of E); other ENM hazard data
can also be taken into account at this stage (e.g., a band (B) is
given to those ENM considered as irritant, a band (C) is given
to an irritant that also causes burns). A table built based on
expert elicitation with pre-assigned hazard bands is provided in
the Stoffenmanager Nano tool for selected ENMs (i.e., C60, car-
bon black, Ag, Fe, Au, Pb, La, TiN, TiO2, CeO2, ZnO and
others such as nanoclay and polystyrene) [54]. In general, how-
ever, the hazard band assignment in Stoffenmanager Nano is
dependent upon the assessor’s judgement and/or the guidelines/
thresholds provided by the tool developers.
In the second step, the user has to select an exposure band value
(range of 1 to 4, where 1 and 4 represent the lowest and highest
exposure, respectively). The exposure band is assigned via
scores (termed multipliers in the Stoffenmanager Nano tool)
which take on numerical values proposed by the authors based
on previously published data and or expert elicitation [54]. The
scores provided by Stoffenmanager Nano tool are for various
factors that influence exposure (e.g., substance emission poten-
tial, handling/activity emission potential, localized controls,
segregation, dilution/dispersion, personal behavior, separation/
personal enclosure, surface contamination, and respiratory
protective equipment) for the industrial process/setting under
consideration. Scores are then assigned to 4 bands depending on
their value range. Once the hazard and exposure bands are
assigned, a matrix is built that qualitatively combines the hazard
(columns A–E) and exposure bands (rows 1–4) to yield the
priority band (scale of 1–3, where 1, 2 and 3 are for high medi-
um and low priorities, respectively, for exposure control).
Following the above approach, for example, the highest priority
(band 3) is associated with ENMs having both the highest
hazard and highest exposure bands.
The Stoffenmanager Nano framework is particularly suited to
situations where the industrial processes involving ENMs are
known and where there is potential for inhalation exposure. Ap-
plication of Stoffenmanager Nano allows the user to rank/priori-
tize ENMs based on potential worker exposure, which can be
useful in situations where decisions must be made with limited
data.
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Table 2: Decision needs and recommended ENMs relevant risk assessment frameworks for selected regulatory decision-making scenarios.
Scenario Example and desired output of analysis Potential framework for use/ currently available
frameworks
Scenario I: Company
deciding whether to control
exposure to workers during
manufacturing or processing
of ENMs.
A company is producing a new ENM and
needs to identify the controls necessary
to protect their workers.
Swiss Precautionary Matrix; DuPont NanoRisk [41];
Control Banding (CB Nanotool) [53]; Web-Based Tool
for Risk Prioritization of Airborne Manufactured Nano
Objects (Stoffenmanager Nano) [54].Internal risk management strategy
including recommended engineering
controls, administrative controls
Scenario II: Regulatory body
deciding whether to control
exposure to workers during
manufacturing or processing.
OSHA deciding whether to establish
Occupational Exposure Limits
(OEL)/Permissible Exposure Limits (PEL)
for a specific class of ENMs.
Risk based classification for occupational exposure
control (Risk based OEL) [51], SPM [31].
Evidence based recommendations or
requirements for allowed exposure.
Scenario III: Company
deciding whether risk
associated with producing a
nanoparticle or nano-enabled
product is manageable.
Company needs to assess the potential
impacts of the production of a
nano-enabled product and how to
manage risks if any.
Web-Based Tool for Risk Prioritization of Airborne
Manufactured Nano Objects (Stoffenmanager Nano)
[54]; Risk classification based on an Industry
Insurance Protocol (RCIP) [52]; An Adaptive
Screening-Level Life Cycle Risk-Assessment
Framework for Nanotechnology (Nano LCRA) [50,55].
Risk assessment of a particular ENM and
risk management strategy.
Scenario IV: Company
deciding which nanoparticle
or nano-enabled product
poses less risk than
alternatives for a particular
application.
Company interested in a precautionary
approach for safe-by-design applications.
Multi-criteria Decision Analysis (MCDA) [34], Life
Cycle Analysis [40], FINE (Forecasting the Impacts of
Nanomaterials in the Environment) based on
Bayesian Networks [48], modified GreenScreen [52].
Assessment or comparison of alternatives
in terms of environmental impacts and
technical performance.
Scenario V: Regulatory body
deciding whether to control
environmental use, release,
or emissions of an ENM.
US EPA deciding whether to issue a
Significant New Use Rule (SNUR) under
TSCA (Toxic Substances Control Act) for
a particular type of ENM.
US EPA’s Comprehensive Environmental Analysis
(CEA) [42]; Risk Assessment Framework for
Assessing Metallic Nanomaterials of Environmental
Concern (NanoHAZ) [87]; A risk quantification based
on probabilistic flow modeling analysis (PMFA);
Forecasting the Impacts of Nanomaterials in the
Environment (FINE) based on Bayesian Networks
[48]; Nano material risk-screening tool (NRST) [45].
Substantial evidence to indicate that a
specific ENM will present an
unreasonable risk to people or the
environment.
Scenario VI: Regulatory body
deciding whether to allow
nanoparticles to be included
in food, drugs, personal care
products.
US FDA deciding whether to allow
registration of a new nano-enabled
product in food (whole food, dietary
supplement, food ingredient or additive),
medical devices, drugs or cosmetics.
NanoRiskCat [35]; Engineered Nanoparticles –
Review of Health and Environmental Safety: Human
health and Ecological Risk Assessment (ENRHES
RA) [46]; DF4Nano [36].
Safety assessment for cosmetic products or a Risk Evaluation and Mitigation Strategy (REMS) for a new drug [30].
Evaluation of the different risk assessment
frameworks
To assess the utility of available risk assessment frameworks for
ENMs described above, the following questions were posed:
1. What is the intent of the framework and who are the
potential users/decision makers for which the frame-
work is designed?
2. What is the level of resolution/type of results needed by
the potential decision makers to be able to make risk
management decisions about the target ENMs?
3. What is the level of expertise that the user must possess
to conduct the analysis using the framework?
When addressing the first question, each framework was evalu-
ated to determine if it addresses one or more of the six different
decision-making scenarios described in the Methods section and
in Table 2. Existing frameworks, which are most suitable for
each of the posed decision-making scenario were also identi-
fied (Table 2). Lastly, for each decision-making scenario the
critical needs that are not met by any of the existing frame-
works were identified.
Suitable frameworks for Scenario I (“A company
needs to decide whether to control exposure to
workers during manufacturing or processing of
ENMs”)
The most suitable existing frameworks for Scenario I are the
Swiss Precautionary Matrix (SPM) [31], the DuPont NanoRisk
[41], Control Banding Nanotool [53], and Stoffenmanager Nano
[54]. Each one of these frameworks has different capabilities
that companies can use to assess the need for controlling
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workers’ exposure to ENMs. For example, SPM can be used to
identify hazards and/or the need for further actions in terms of
risk management related to manufacturing processes of ENMs.
SPM allows for rapid assessment of known/unknown informa-
tion (first tier assessment). The questions posed in SPM are
mostly qualitative and designed to determine whether or not the
user is dealing with a material that is considered to be classified
as “nano”. SPM was developed by the Swiss Federal Office of
the Environment and the Federal Office of Public Health.
Therefore, SPM includes pertinent regulatory definitions for
nanomaterials (relevant for Switzerland) and provides useful
guidelines to industry users wishing to comply with environ-
mental health and safety regulations. The downside is that this
framework does not include a detailed analysis of industrial
processes with respect to parameters related to worker safety
(e.g., the number of employees exposed, frequency of exposure,
control measures already in place). Another limitation is that
SPM does not provide the analyst with specific recommenda-
tions for implementation of industrial hygiene controls.
The DuPont NanoRisk framework can address the specific
needs for a risk management strategy through ENM life cycle
profiles. This framework is suitable for decision making related
to controlling worker exposures because the DuPont NanoRisk
framework requires the analyst to provide lifecycle, exposure
and hazard profiles for the material of interest. The challenge
with the DuPont NanoRisk framework, however, is that it
requires input of a significant body of information in addition to
conducting a chemical process risk assessment (CPQRA).
Banding approaches such as the Control Banding Nanotool and
Stoffenmanager Nano are useful for classifying ENMs and
establishing risk management needs (e.g., reducing working
exposure via engineering controls, personal protection equip-
ment and other measures). Because CB Nanotool involves the
identification and quantification of extensive characteristics of
the industrial processes (e.g., number of workers potential
exposed, frequency of exposure, concentrations that the workers
could be exposed to), it allows the user to tailor protective
measures to the company’s needs. Two primary disadvantages
of CB Nanotool are that it requires significant user data input,
and that the procedure or the decision regarding the “bands” is
highly dependent on the knowledge/expertise of the assessor.
Stoffenmanager Nano also requires extensive input information
input by the analyst. However, Stoffenmanager Nano takes into
consideration the use of personal protective equipment (PPE)
and current industrial hygiene (IH) practices; hence, this ap-
proach is useful for reviewing current practices and for leading
the analyst to identify possible needs for modifying current
practices. Another advantage is that Stoffenmanager Nano is
accessible as a web-based tool.
Suitable frameworks for Scenario II (“Regulatory bo
dy that has to decide whether to control exposure to
workers during ENM manufacturing or processing”)
In Scenario II, the stakeholders wish to establish an evidence
based exposure limit (e.g., OSHA established safe exposure
level setting) for an ENM of concern. Of the existing frame-
works, the Risk-based OEL framework proposed [51,83] is
most suitable for this scenario, particularly in cases where a
benchmark dose for a reference material (e.g., for a correspond-
ing bulk material or ultrafine material) is available. The risk-
based OEL framework also offers the advantage of identifying
specific/minimum data required for conducting an assessment,
which allows users to prioritize future research and data collec-
tion. However, the applicability of this framework is limited to
assessment of ENMs for which well characterized ultrafine
counterparts exist; therefore, the approach may have limited
utility for next generation ENMs for which well-characterized
reference materials are not available. Additionally, given the
SPM parameters (potential effect (W), potential exposure of
humans or environmental release (E), and available informa-
tion on the material’s life cycle) [31] this framework could be
useful for the regulatory agency to identify potential ENMs of
concern, hence preventing workers’ exposure.
Suitable frameworks for Scenario III (“A company
that needs to decide if the risk(s) associated with
producing a nanoparticle or nano-enabled product is
manageable”)
In Scenario III, the stakeholders are individuals working for a
company that needs to ascertain whether the risks associated
with producing a nanoparticle or nano-enabled product can be
reasonably managed. The most suitable frameworks for this
scenario are the: Web-Based Tool for Risk Prioritization of
Airborne Manufactured Nano Objects (Stoffenmanager Nano),
Risk Classification based on an Industry Insurance Protocol
(RCIP), and Life Cycle Risk Analysis (Nano LCRA). Each of
these frameworks allows the analyst to assess impacts related to
production of certain ENMs and to identify risk management/
reduction strategies. Stoffenmanager Nano is suitable for this
scenario as it allows one to design risk reduction/management
strategies for each of the “risk bands”, which can then be
applied to any ENM that meets the classification criteria for
each risk band. Stoffenmanager Nano requires detailed informa-
tion about both the ENM and the associated industrial handling
operations. The above is needed to arrive at informative strate-
gies to manage risks associated with the material. However, it is
important to note that the above framework only provides a
mechanism for qualitative assessment and suggestions of
control measures of occupational risks, and risks related to
potential releases to the environment that might occur during
manufacturing.
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The risk classification approach based on an insurance protocol
framework is also suitable for Scenario III since it considers an
“incident/accidental release scenario”. In this framework, a
measure of the overall risk is calculated and the potentials for
accidents are considered. This framework provides a detailed
protocol, with the pertinent mathematical expressions, to calcu-
late aggregate scores for parameters that affect risk (i.e., hazard
and exposure). One limitation of this framework is that the risks
associated with an ENM are calculated based on emissions,
exposure potential and hazards of the chemicals involved in the
synthesis of ENMs, not those for the actual ENM itself. Admit-
tedly, the above limitation could also be perceived as an advan-
tage if there is limited data for industry to assess the target
ENM. Another limitation of the RCIP framework is that it does
not address the development of risk management strategies.
Whereas both the Stoffenmanager Nano and RCIP frameworks
focus primarily on risks related to manufacturing/synthesis of
ENMs, NanoLCRA takes into account the potential risks attri-
buted to the ENM throughout its lifecycle. A shortcoming of the
NanoLCRA framework is that it does not provide a specific
methodology for quantifying risk (e.g., steps for aggregation of
scores, guideline tables to assign exposure/risk bands, or mathe-
matical equations to derive reference values, and benchmark
doses). Moreover, the framework relies entirely on an expert
evaluation of the available information.
Suitable frameworks for Scenario IV (“A company
that needs to decide as to which nanoparticle or
nano-enabled product poses less risk than
alternatives for a particular application”)
In Scenario IV, the stakeholders are individuals representing a
company that desires to identify the safest ENM for a particular
application. The most suitable existing frameworks are: Multi-
Criteria Decision Analysis (MCDA), Life Cycle Analysis
(LCA), BN FINE and modified GreenScreen. MCDA [34] is
appropriate for Scenario IV because it allows comparison
among alternatives. For example, MCDA was demonstrated for
ranking the relative risk potential of a set of ENMs based on
hazard related properties (e.g., agglomeration, potential to form
ROS, reactivity, etc.) [34]. MCDA provides a framework for
assessing properties related to hazard and, in doing so, allows
the analyst to identify critical properties that could be modified
to develop safer ENMs. The disadvantages of applying MCDA
to ENMs, at least as is currently proposed in the literature
[32,34,60], are that the approach relies primarily on expert judg-
ment and that MCDA does not consider causal relationships
(e.g., relating a specific ENM property to an adverse outcome).
LCA [40] is also suitable for companies that need to consider
Scenario IV. This is because LCA provides a framework for
assessing environmental impacts throughout the ENM life cycle
(synthesis, use, and disposal). The use of LCA, however,
requires a significant data (e.g., emission inventories for all
chemicals involved in the manufacture of ENMs throughout
their lifecycle).
BN FINE [48] is another useful framework for companies that
need to address the above Scenario IV. Given that BN FINE
involves the use of an influence diagram, which incorporates
causal relationships between ENM properties and risk parame-
ters, the approach can assist in identifying the relevant ENM
properties that can be tailored to manufacture safe ENMs (i.e.,
“safer-by-design”) [88]. In the absence of quantitative data,
expert judgement can be incorporated into the BN framework
[48]; however, the framework developer must be able to iden-
tify the critical causal relationships (e.g., between ENM physi-
cochemical properties, environmental conditions and risk
outcomes). Although the BN approach is extremely powerful,
construction of a BN based framework requires ENM specific
data.
The modified GreenScreen [37,65] approach is another frame-
work that can be partially suitable for Scenario IV as it allows
analysts to perform rapid screening of potential hazards among
a group of ENMs for which data are available. The scores pro-
vided by GreenScreen are designed to make recommendations
regarding the need for additional information or for seeking
safer ENMs. This framework is suitable for hazard assessment
for Scenario IV but is not a substitute for risk assessment.
Suitable frameworks for Scenario V (“Regulatory
body that needs to decide whether or not to control
environmental use, release, or emissions of an
ENM”)
Several existing frameworks are suitable for Scenario V, includ-
ing US EPA’s own Comprehensive Environmental Assessment
CEA [42,43], Nano HAZ [87], a risk quantification based on
probabilistic flow modeling analysis (PMFA RQ) [47], BN
FINE [48], and the Nanomaterial Risk-Screening Tool (NRST).
CEA is useful for regulatory decision analysis (e.g., regarding
issuance of Significant New Use Rule (SNUR) for a new ENM)
because it can be used to systematically organize information.
CEA provides a framework that allows decision makers to
assemble and review data that are critical for determining
whether a SNUR should be issued; such data includes, for ex-
ample, the projected volume of manufacturing and processing,
extent to which the novel ENM changes the exposure of human
beings or the environment, and the anticipated manner and
methods of manufacturing, processing, distribution in com-
merce, and disposal of a chemical substance. Advantages of the
CEA framework include the provision of list/guidelines
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regarding the information needed for a comprehensive assess-
ment, and the availability of a survey tool (“CEA web tool”) as
a platform for eliciting expert information.
NanoHAZ and PMFA RQ are also suitable for use by regula-
tors who are confronted with the need to reduce the potential
environmental and health impacts of a specific ENM via restric-
tions on its environmental releases and use. NanoHAZ is specif-
ically designed to provide qualitative estimations of risks for
metallic ENMs in water treatment plants, via mass balance esti-
mation of concentrations and with use of literature derived
hazard data. Risk can also be estimated quantitatively in the
PMFA RQ framework. It is noted that the PMFA RQ frame-
work can also take into account local geographical and meteo-
rological conditions and specific hazard data if these are avail-
able. It is emphasized that both NanoHAZ and PMFA RQ
require the analyst to provide judgment as to whether the calcu-
lated risk is significant or unreasonable; such a request for
information essentially implies that the analyst is knowledge-
able regarding the implications of the various assumptions made
by the frameworks’ developers.
Bayesian Network (BN) approaches like BN FINE can also be
suitable for used under Scenario V. One advantage of this ap-
proach is that it allows incorporation of both quantitative and
qualitative (including expert knowledge) data. BN offer the ad-
ditional advantage of being able to conveniently refine/modify
the BN as additional information becomes available (i.e., via
incremental learning). Two additional advantages of BN FINE
for regulators are that this framework can address ecological
risks and can quantify uncertainties, thus assisting regulators in
determining whether or not the calculated risk is significant/
unreasonable.
Finally, the Nanomaterial Risk-Screening Tool (NRST) is a
suitable framework for Scenario V because it takes into consid-
eration both potential human and ecological risks associated
with ENMs. However, given that this framework requires
expert judgment regarding available information (and does not
incorporate quantitative data), there may be a concern that
potential bias could be introduced.
Suitable frameworks for Scenario VI (Regulatory
body deciding whether to allow nanoparticles to be
included in food, drugs, personal care products)
NanoRiskCat [35], ENRHES RA [46] and DF4Nano [36] are
the most suitable frameworks available for Scenario VI because
they focus on safety assessment for consumer products (e.g.,
new cosmetics or drugs applications), but each of them has sig-
nificant limitations. NanoRiskCat is particularly useful for iden-
tifying potential exposure scenarios related to use of consumer
products. Analysis via this framework, however, requires access
to data regarding the form in which the ENM is present in the
consumer product (e.g., as a spray, embedded in a solid film), as
well knowledge of potential scenarios that can lead to ENM
release to the environment. NanoRiskCat is also a suitable
screening approach for identifying the need for more specific
safety assessments. A major limitation, however, is that
NanoRiskCat does not meet the requirements of REMS (Risk
Evaluation and Mitigation Strategy); thus, it is less suitable for
formal regulatory risk evaluation.
The DF4Nano framework can also be used to conduct a rapid
assessment of human health hazards. If sufficient ENMs charac-
terization data are available to allow a new ENM to be grouped
with existing (better characterized) ENMs based on its proper-
ties, then DF4Nano can be used to classify the ENM risk poten-
tial in the absence of extensive toxicity data. One major limita-
tion is that DF4Nano does not account for other product compo-
nents or transformation of ENMs during product manufacturing.
The Human Health and Ecological Risk Assessment frame-
work within the project “Engineered Nanoparticles – Review of
Health and Environmental Safety” (ENRHES RA) can also be
suitable under Scenario VI. One advantage of the ENRHES RA
framework is that it can serve to estimate the risk potential of
ENMs in consumer products, provided that data are available
regarding ENMs properties and potential for release after incor-
poration into consumer products. A limitation of ENRHES RA
is that it requires quantitative dose–response data and informa-
tion regarding the potentially exposed population and exposure
scenarios to be able to quantitatively assess the risks associated
with a particular ENM.
Conclusions
Over the last decade, a number of different analysis frame-
works have been developed with the goal of providing evi-
dence-based approaches to making practical decisions related to
the potential risk associated with ENMs. The utility of these
frameworks should be assessed based on the intent for making
the decisions regarding the potential risk of ENMs and the level
of decision making (i.e., who is and/or what is the authority of
the decision maker?). Accordingly, the current review of
existing frameworks for assessing the potential environmental
and health impacts of ENMs evaluated the applicability of dif-
ferent frameworks based on six plausible decision scenarios.
These scenarios were designed to describe the most common
and pressing needs by critical stakeholders to arrive at deci-
sions respecting the environmental health and safety of engi-
neered nanomaterials (Table 2). For each of the explored deci-
sion scenarios, at least one existing framework was identified as
being capable of partly meeting the needs of potential decision
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makers. Limitations and advantages of the different frame-
works and associated available tools were then identified in
relation to the needs for decision analysis.
Several of the existing frameworks were assessed to partially
meet the needs of manufacturers and regulatory bodies seeking
to identify measures for reducing or controlling workers’ expo-
sure to ENMs during manufacture and other industrial activi-
ties (Scenarios I and II). These include the Swiss Precautionary
Matrix, DuPont NanoRisk, Control Banding (CB Nanotool),
and the Web-Based Tool for Risk Prioritization of Airborne
Manufactured Nano Objects (Stoffenmanager Nano)). Each of
these frameworks focuses on evaluating different activities that
may lead to ENM exposure and incorporates hazard informa-
tion to help the analyst develop and prioritize risk and exposure
control measures for ENMs. However, because the above
frameworks consider inhalation as the sole exposure pathway
(with the exception of NanoRisk), they are of limited applicabil-
ity to decision makers who wish to assess other exposure path-
ways (e.g., oral and dermal exposures).
Several frameworks that companies can use to assess or
compare risks associated with production of nano-enabled prod-
ucts (Scenarios III and IV) are available; however, each of these
frameworks requires either expert judgement, proprietary soft-
ware packages, and/or extensive hazard data for the ENMs of
interest. For instance, MCDA, LCA, BN FINE, Stoffenman-
ager Nano, RCIP, Nano LCRA frameworks all require access to
extensive ENM toxicity and/or exposure data. MCDA and Nano
LCRA also require expert judgment, while RCIP and BN FINE
require significant expertise and use of external software pack-
ages.
Several frameworks have been designed to meet the need of
decision makers (e.g., US EPA and US FDA) who wish to
assess the potential impact of environmental releases of ENMs
and safety of commercial products (Scenarios V and VI). How-
ever, each of these frameworks also has significant limitations.
For example, the ability of regulatory decision makers to use
CEA, NanoHAZ, PMFA, BN FINE, NRST, NanoRiskCat,
ENRHES RA frameworks is limited to the types of hazard and
exposure data that are currently available for ENMs. Because
hazard and exposure data are typically only available for ENMs
as manufactured, the above tools are not directly applicable for
assessing risks posed by ENMs that have been transformed
through their incorporation in nano-enabled products or their
transformation in the environment. It is also noted that frame-
works such as US EPA’s CEA and NRST do not include tools
to integrate quantitative and qualitative information about
hazard and exposure, and rely heavily on expert judgment to
identify the data needed for the analysis.
Despite significant advances that have been made in the area of
risk assessment associated with ENMs, the currently available
frameworks do not provide a pragmatic, flexible and compre-
hensive approach that would meet the needs of all the critical
categories of decision makers and decision scenarios. Given the
varied decision analysis objectives it is not surprising that dif-
ferent risk assessment frameworks have been proposed at differ-
ent levels of complexity, different data needs and with different
outcome objectives. At present, the existing frameworks do not
provide a convenient and transparent mechanism for inte-
grating results from modeling tools with experimental and
industry reported data. As a result, each of the existing frame-
works is limited by the relatively incomplete exiting hazard and
exposure data for ENMs. Given the rapid developments in
nanotechnology, it would be highly desirable to develop an inte-
grated framework that could provide an efficient mechanism for
managing and integrating quantitative and qualitative informa-
tion while also accounting for the impact of missing informa-
tion as part of the analysis. Ideally, such a framework would
also provide guidance to decision makers (in the absence of
expert judgement) regarding the information needed to conduct
decision analysis for specific scenarios that are of interest.
In closure, based on the present review of various risk assess-
ment frameworks it is suggested that further research should
focus on the development of integrative frameworks for
assessing the risk potential of ENMs that: a) address the
complexities of ENMs and their transformations, b) integrate
quantitative and qualitative data, c) allow use of modeling tools
to fill data gaps, d) minimize reliance on expert judgement, and
e) enable quantification of uncertainties associated with the use
of both quantitative and qualitative data/information. Such
frameworks would not only be of practical use for decision
makers in a variety of contexts, but would also provide evi-
dence-based approaches for prioritizing future research and
manufacturing of ENMs and related products in support of en-
vironmentally sustainable nanotechnology.
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